Serbia
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products and we aim to bring differentiated, high-quality and needed healthcare products to as many people as possible in Serbia.
Contact details
For medical information
To report an adverse event
For questions on our Ellipta portfolio
Please contact Berlin-Chemie A. Menarini Distribution d.o.o.
Tel: +381 (0) 11 655 6090 or +381 (0) 11 655 6091
Email: office@berlin-chemie.rs
For questions on distribution and supply of medicines and vaccines
Please contact PHOENIX Pharma d.o.o.
Tel: +381 (0) 11 35 38 100
Email: office@phoenixpharma.rs
Please contact Dimidijus Pharm
Tel: +381 (0) 11 27 600 98 or +381 (0) 1127 600 99
Email: dimidijus.pharm@gmail.com
Please contact Institut Za Virusologiju, Vakcine i Serume "Torlak"
Tel: +381 (0) 11 3953 700
Email: office@torlak.rs
Please contact Farmalogist d.o.o.
Tel: +381 (0) 11 331 5069
Email: office.centar@farmalogist.rs
Please contact Sopharma Trading d.o.o.
Tel: +381 (0) 11 442 8002
Email: office@sopharmatrading.rs
For government and media enquiries
Please contact: WW.CEEurope-media@gsk.com
Back to topEFPIA disclosure
GSK fully supports the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on the disclosure of individual transfer of value from pharmaceutical companies to healthcare professionals and healthcare organisations. We believe that it helps to create a better understanding about how the pharmaceutical industry partners and collaborates with HCPs and HCOs, and so increase confidence in the way that industry and the healthcare professions work together.
We publish disclosure reports in line with the EFPIA Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations. View our disclosure report for Serbia.